MYC and cancer: In human hepatocellular carcinoma SMMC-7721 cells, in addition to low β-catenin both in the cytoplasm and nucleus by promoting its phosphorylation (Ser33/37/Thr41), the compound also caused target genes c-Myc and cyclin D1 to decrease, reducing a wide range of cancer properties [91].